SM
CSCI

Sabby Management’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Sabby Management’s Portfolio CSCI Stock Details CSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5
Closed -$53K – 190
2021
Q1 		$53K Buy
+5
New +$554 0.01% 153
2018
Q1 		– Sell
-1
Closed -$33K – 185
2017
Q4 		$33K Buy
+1
New +$208 ﹤0.01% 152

Other funds holding CSCI

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Sabby Management's CSCI Position: Q3 2021 in Review

Sabby Management sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q3 2021, closing a stake of 2,442 shares — an estimated $214K sold.

Sabby Management first reported a position in CSCI in Q4 2015 and held it in 11 quarters. The position peaked at $2.39M in Q4 2015. 31 funds tracked by Wall St. Rank hold CSCI as of Q3 2021.

  • Sabby Management reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Sabby Management sold 2,442 COSCIENS Biopharma Inc. Common Stock shares in Q3 2021, an estimated $214K.
  • Sabby Management first reported a position in COSCIENS Biopharma Inc. Common Stock in Q4 2015 and held it in 11 quarters.
  • Sabby Management's COSCIENS Biopharma Inc. Common Stock position peaked at $2.39M in Q4 2015.
  • 31 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q3 2021.

Based on Sabby Management's 13F filing for Q3 2021, filed 15 Nov 2021.